Abstract Motivation Deep generative models have transformed drug molecule generation. However, molecules exhibit complex hierarchical structures, requiring models to simultaneously balance macroscopic topological coherence and microscopic chemical self-consistency. Although autoregressive (AR) and discrete diffusion paradigms are highly complementary, integrating their advantages within a unified architecture remains severely limited by traditional “atom-by-atom” fine-grained modeling. Results We propose MARD-Mol, a hybrid AR-diffusion framework based on motif-inspired units. By elevating the representation granularity from atoms to motif-inspired units and introducing a dual-stream hierarchical attention mechanism, it couples inter-unit AR global scaffold planning with intra-unit discrete diffusion generation. To support goal-directed drug discovery, we reformulate property optimization into an iterative “diagnose-and-repair” process, enabling targeted optimization of defective motifs while preserving the global scaffold. Extensive experiments demonstrate that MARD-Mol achieves an 86.0% Quality score in de novo generation and exhibits superior performance in fragment-constrained and multi-objective optimization, establishing a new paradigm for high-quality drug design. Availability and implementation The source code and datasets used in this study are available at GitHub: https://github.com/CSUBioGroup/MARD-Mol.
Sizhe Zhang, G. Luo, Wei Fan et al.· Bioinformatics· 0 citations
The results demonstrate the effectiveness of integrating multi-scale and multi-modal representations with cross-scale alignment for protein–RNA affinity prediction, and suggest that M2-PRNet can highlight relevant RNA-binding regions and support preliminary discrimination between strong and weak binders when plausible complex structures are available.
Junkai Wang, G. Luo, Yun-Song Yang et al.· Bioinformatics· 0 citations
This work designs a biological prior-guided feature fusion framework that integrates pseudo-structural epitope knowledge and CDR-specific attention mechanisms via a mixture-of-experts architecture to effectively capture complex binding landscapes in antibody screening and drug residence time analysis.
G. Luo, Junkai Wang, Sizhe Zhang et al.· Bioinformatics· 0 citations